This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Has Vista Outdoor (VSTO) Outpaced Other Consumer Discretionary Stocks This Year?
by Zacks Equity Research
Is (VSTO) Outperforming Other Consumer Discretionary Stocks This Year?
Marriott (MAR) Continues to Expand Foothold in South Asia
by Zacks Equity Research
Marriott (MAR) consistently trying to expand presence worldwide and capitalize on the demand for hotels in international markets.
Are Investors Undervaluing Vista Outdoor (VSTO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Choice Hotels (CHH) Boosts Ascend Line-up With New Hotels
by Zacks Equity Research
Choice Hotels' (CHH) Ascend brand unveils a range of hotels for travelers seeking outdoor adventure. The company has hotels in North Carolina, New Mexico, Maryland and Michigan.
Expansion Efforts Support Marriott (MAR) Stock, RevPAR Dismal
by Zacks Equity Research
Marriott's (MAR) focus on the loyalty program and promotional offers bodes well. However, dismal RevPAR due to the coronavirus pandemic is a concern.
Choice Hotels' (CHH) Ascend & Cambria Brands Post Solid Growth
by Zacks Equity Research
Choice Hotels' (CHH) upscale brands, the Ascend Hotel Collection and Cambria Hotels, continue to drive the company's performance.
Vista Outdoor (VSTO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Vista Outdoor (VSTO) closed at $40.78 in the latest trading session, marking a -1.88% move from the prior day.
Choice Hotels (CHH) Strategies Look Strong: Should You Retain?
by Zacks Equity Research
Choice Hotels' (CHH) focus on franchising initiatives and strategic conversions bode well. However, lag in occupancy is a concern.
5 Stocks With Amazingly Low EV-to-EBITDA Ratios to Snap Up
by Anindya Barman
We have screened value stocks VSTO, HZO, BCC, GEF and OC based on EV-to-EBITDA ratio that offers a clearer picture of valuation and earnings potential.
Vista Outdoor (VSTO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Vista Outdoor (VSTO) closed at $41.47 in the latest trading session, marking a +0.07% move from the prior day.
Is Vista Outdoor (VSTO) Outperforming Other Consumer Discretionary Stocks This Year?
by Zacks Equity Research
Is (VSTO) Outperforming Other Consumer Discretionary Stocks This Year?
Should Value Investors Buy Vista Outdoor (VSTO) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Callaway Golf (ELY) Raises Guidance for Q3 & 2021, Stock Up
by Zacks Equity Research
Callaway Golf (ELY) is benefiting from Topgolf business, mostly its walk-in and social events business. For third-quarter 2021, the company anticipates net revenues in the range of $850 million to $860 million.
What's in Store for Academy Sports and Outdoors' (ASO) Q2 Earnings?
by Zacks Equity Research
Academy Sports and Outdoors (ASO) second-quarter 2021 results are likely to reflect robust consumer demand across all markets and merchandise divisions.
Robust Unit Shipments to Aid Smith & Wesson's (SWBI) Q1 Earnings
by Zacks Equity Research
Smith & Wesson (SWBI) first-quarter fiscal 2022 margin likely to reflect benefits from increased unit shipments and lower promotional activity.
Is Vista Outdoor (VSTO) Outperforming Other Consumer Discretionary Stocks This Year?
by Zacks Equity Research
Is (VSTO) Outperforming Other Consumer Discretionary Stocks This Year?
Should Value Investors Buy Vista Outdoor (VSTO) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Peloton (PTON) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Peloton (PTON) fiscal fourth-quarter results are likely to reflect surge in demand for its in-house exercise equipments like Bike and Bike+, and purchase of Precor.
Combat the Choppy Market With These 5 Low-Beta Stocks
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through choppy market conditions. CHWY, REGN, VSTO, RGR & CICHY are the frontrunners.
Zacks.com featured highlights include: ArcelorMittal, Vista Outdoor, Owens Corning, Greif and TTM Technologies
by Zacks Equity Research
Zacks.com featured highlights include: ArcelorMittal, Vista Outdoor, Owens Corning, Greif and TTM Technologies
5 Value Stocks With Impressive EV-to-EBITDA Ratios to Own Now
by Anindya Barman
We have screened value stocks MT, VSTO, OC, GEF and TTMI based on EV-to-EBITDA ratio that offers a clearer picture of valuation and earnings potential.
Vista Outdoor (VSTO) Is Up 6.64% in One Week: What You Should Know
by Zacks Equity Research
Does Vista Outdoor (VSTO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Vista Outdoor (VSTO) Outperforming Other Consumer Discretionary Stocks This Year?
by Zacks Equity Research
Is (VSTO) Outperforming Other Consumer Discretionary Stocks This Year?
Is Vista Outdoor (VSTO) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: Vista Outdoor, Canon, Apollo Medical, Tyler Tech and ResMed
by Zacks Equity Research
Zacks.com featured highlights include: Vista Outdoor, Canon, Apollo Medical, Tyler Tech and ResMed